Derivatives of isothiazol-3(2H)-one 1,1-dioxides as Liver X Receptor modulators

Details for Australian Patent Application No. 2006204161 (hide)

Owner AstraZeneca AB

Inventors Sandberg, Pernilla; Westerlund, Christer; Bostrom, Jonas; Li, Lanna; Brickmann, Kay; Judkins, Robert; Swanson, Marianne; Broo, Anders; Holm, Patrik

Agent Davies Collison Cave

Pub. Number AU-B-2006204161

PCT Pub. Number WO2006/073363

Priority 0500053-4 10.01.05 SE; 0501628-2 08.07.05 SE

Filing date 9 January 2006

Wipo publication date 13 July 2006

Acceptance publication date 19 November 2009

International Classifications

C07D 275/03 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

A61K 31/425 (2006.01) - Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4725 (2006.01)

A61K 31/5377 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/073363 Priority application(s): WO2006/073363

19 November 2009 Application Accepted

  Published as AU-B-2006204161

18 March 2010 Standard Patent Sealed

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204164-Non-anilinic derivatives of isothiazol3(2H)-one 1,1-dioxides as Liver X Receptor modulators

2006204159-Novel pyridine compounds